Cost-effectiveness of Selected Immunisation Programs in Australia
für 53.10€ kaufen ··· 9783846504048 ··· 10361146435 ··· Health care costs are on the rise in Australia. Rational decisions using cost-effectiveness analyses are necessary to prioritise health interventions for the allocation of limited resources. Immunisation is an important component of preventive health care intervention and its cost-effectiveness analyses are useful in prioritising the choices. This book describes economic evaluation of two immunisation interventions in Australia: influenza and hepatitis B. We have analysed cost-effectiveness of reducing universal influenza vaccination age threshold to 50 from the current 65 using a decision tree model and cost-effectiveness of various hepatitis B infant vaccination strategies using a micro-simulation model. Here we describe the strength of the evidence to reduce universal influenza vaccination age threshold. Our results also suggest that the current hepatitis B vaccination strategy in Australia is an expensive one, but yields maximum health gain in general population. Is that the best choice How good is Australian hepatitis B immunization strategy for indigenous population Do we have alternative cost-effective choices This book tries to explore all these questions. Hersteller: LAP Lambert Academic Publishing Marke: LAP Lambert Academic Publishing EAN: 9783846504048 Kat: Hardcover/Naturwissenschaften, Medizin, Informatik, Technik/Medizin Lieferzeit: Sofort lieferbar Versandkosten: Ab 20¤ Versandkostenfrei in Deutschland Icon: https://www.inforius-bilder.de/bild/?I=t1S4%2BQV1nzc10FvLiO9bcbRw7bRY5F8AIJvRUQ6Dg0s%3D Bild: